High-Dose Atorvastatin after Stroke or Transient Ischemic Attack (vol 355, pg 549, 2006)

被引：0
|
作者：
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 378卷 / 25期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2450 / 2450
页数：1
相关论文
共 50 条
  • [1] High-dose atorvastatin after stroke or transient ischemic attack
    Amarenco, Pierre
    Bogousslavsky, Julien
    Callahan, Alfred, III
    Goldstein, Larry B.
    Hennerici, Michael
    Rudolph, Amy E.
    Sillesen, Henrik
    Simunovic, Lisa
    Szarek, Michael
    Welch, K. M. A.
    Zivin, Justin A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (06): : 549 - 559
  • [2] High-dose atorvastatin after stroke or transient ischemic attack. Results of the SPARCL study
    Lyakishev, A. A.
    KARDIOLOGIYA, 2006, 46 (10) : 70 - 71
  • [3] Effect of High-Dose Atorvastatin on Renal Function in Subjects With Stroke or Transient Ischemic Attack in the SPARCL Trial
    Amarenco, Pierre
    Callahan, Alfred, III
    Campese, Vito M.
    Goldstein, Larry B.
    Hennerici, Michael G.
    Messig, Michael
    Sillesen, Henrik
    Welch, K. Michael A.
    Wilson, Daniel J.
    Zivin, Justin A.
    STROKE, 2014, 45 (10) : 2974 - 2982
  • [4] The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review
    Fang, Jing-xue
    Wang, Er-qiang
    Wang, Wei
    Liu, Yang
    Cheng, Gang
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (05) : 679 - 687
  • [5] The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review
    Jing-xue Fang
    Er-qiang Wang
    Wei Wang
    Yang Liu
    Gang Cheng
    Internal and Emergency Medicine, 2017, 12 : 679 - 687
  • [6] High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial
    Schwartz, Gregory G.
    Chaitman, Bernard R.
    Goldberger, Jeffrey J.
    Messig, Michael
    AMERICAN HEART JOURNAL, 2011, 161 (05) : 993 - 999
  • [7] Effect of High-Dose Atorvastatin on Risk of Atrial Fibrillation in Patients with Prior Stroke or Transient Ischemic Attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
    Schwartz, Gregory G.
    Chaitman, Bernard R.
    Goldberger, Jeffrey J.
    Messig, Michael
    CIRCULATION, 2010, 122 (21)
  • [8] Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
    Kernan, W. N.
    Viscoli, C. M.
    Furie, K. L.
    Young, L. H.
    Inzucchi, S. E.
    Gorman, M.
    Guarino, P. D.
    Lovejoy, A. M.
    Peduzzi, P. N.
    Conwit, R.
    Brass, L. M.
    Schwartz, G. G.
    Adams, H. P., Jr.
    Berger, L.
    Carolei, A.
    Clark, W.
    Coull, B.
    Ford, G. A.
    Kleindorfer, D.
    O'Leary, J. R.
    Parsons, M. W.
    Ringleb, P.
    Sen, S.
    Spence, J. D.
    Tanne, D.
    Wang, D.
    Winder, T. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (14): : 1321 - 1331
  • [9] Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
    Hu, Kejia
    Xu, Wendong
    Williams, Ziv
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (07): : 703 - 704
  • [10] High dose Atorvastatin after stroke or Transient Ischaemic Attack (SPARCL) - Does every stroke patient in Pakistan deserve a statin?
    Khan, Maria
    Kamal, Ayeesha Kamran
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2010, 60 (06) : 505 - 506
12345